Analyst stock forecast
NRX Pharmaceuticals, Inc. Forecast: $38.25 Analyst Target
NRXP has a $38.25 target, Strong Buy rating and 4 analysts. As of 2026-08-15.
Direct answer
NRX Pharmaceuticals, Inc.'s average price target is $38.25.
The target implies +1,069.7% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +205.8%, the high target implies +1,398.5%, and the range spans 1,192.7% of the current price.
Forecast evidence checked August 15, 2026.
Get free NRX Pharmaceuticals, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.27
- Average price target
- $38.25
- High price target
- $49.00
- Low price target
- $10.00
- Low target gap
- +205.8%
- Target upside
- +1,069.7%
- High target gap
- +1,398.5%
- Target range width
- 1,192.7%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026
Explore related company data
Read the frequently asked questions.
What is NRX Pharmaceuticals, Inc.'s average price target?
NRX Pharmaceuticals, Inc.'s verified average price target is $38.25. The target range is $10.00 to $49.00.
How far are NRX Pharmaceuticals, Inc.'s low and high targets from the recorded price?
The low target implies +205.8%, while the high target implies +1,398.5%.
How many analysts are included in NRX Pharmaceuticals, Inc.'s consensus?
The verified consensus includes 4 analysts.
How is NRX Pharmaceuticals, Inc.'s target upside or downside calculated?
The average target of $38.25 is divided by the recorded price of $3.27, then one is subtracted to produce +1,069.7%. This does not guarantee a future return.
When was NRX Pharmaceuticals, Inc.'s analyst forecast verified?
The data was verified on 2026-08-15. The dataset is valid through 2026-08-22.